Key Insights

Highlights

Treatment Research

1 treatments under study, led by Blood Draw And Cerebrospinal Fluid Draw

Research Leaders

5 sponsors active, led by Universitätsklinikum Hamburg-Eppendorf

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07111975Active Not Recruiting

ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction

NCT02397759Not ApplicableUnknownPrimary

Metabolomic Profile and Proteasic Activity as Biomarkers for Early Detection of Arterial Vasospas in Arterial Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Showing all 2 trials

Research Network

Common Treatments

  • Blood Draw And Cerebrospinal Fluid Draw1

Active Sponsors

  • Universitätsklinikum Hamburg-Eppendorf1
  • Philips Medical Systems1
  • Assistance Publique Hopitaux De Marseille1
  • UMC Utrecht1
  • Bichat Hospital1

Top Investigators

Related Conditions

  • Intracranial Aneurysms1
  • Unruptured Intracranial Aneurysm1

Activity Timeline